Search for: "Medtronic Inc."
Results 261 - 280
of 1,084
Sorted by Relevance
|
Sort by Date
29 Nov 2010, 12:32 pm
Medtronic, Inc., C.A. [read post]
27 Feb 2008, 12:22 am
Medtronic, Inc., No. 06-179 (U.S. [read post]
7 Aug 2012, 7:27 am
While the Supreme Court may have expanded the reach of the Hatch-Waxman “safe harbor,” the Medtronic and Merck cases only involved pre-marketing FDA approval activity. [read post]
8 Dec 2016, 9:23 pm
Patent No. 8,361,156 in an inter partes review instituted on a petition by Medtronic, Inc. [read post]
5 Jun 2023, 9:15 am
À.R.L. when it upheld Patent Trial and Appeal Board (PTAB) rulings that found Medtronic, Inc. had failed to prove Teleflex’s patent claims for catheter technology used in interventional cardiology procedures unpatentable. [read post]
9 Sep 2017, 9:19 pm
Patent and Trademark Office, Jeffrey Hohenshell of Medtronic, Inc, and Patent Docs author Kevin Noonan of McDonnell Hulbert Berghoff & Boehnen LLP will analyze the opportunities and pitfalls for patent prosecutors raised by restriction requirements, discussing such topics as: • After a restriction requirement, how can a patent applicant make sure that the subsequent application falls into the section 121 "safe harbor," while... [read post]
17 Mar 2018, 8:52 pm
Jeff Hohenshell of Medtronic, Inc., Stephen Kunin of Oblon, and Scott McKeown of Ropes & Gray LLP will discuss why patent prosecutors should be worried about estoppel arising from PTAB proceedings. [read post]
5 Jun 2023, 9:15 am
À.R.L. when it upheld Patent Trial and Appeal Board (PTAB) rulings that found Medtronic, Inc. had failed to prove Teleflex’s patent claims for catheter technology used in interventional cardiology procedures unpatentable. [read post]
25 Feb 2009, 3:53 am
The Wall Street Journal (2/24, Burton) reports that Medtronic Inc.'s Sprint Fidelis defibrillator leads, "pulled from the market in 2007, represent an 'increasing hazard' for more than 200,000 heart patients world-wide," according to "Minneapolis Heart Institute cardiologist Robert G. [read post]
2 Mar 2019, 9:48 pm
., Jeff Hohenshell of Medtronic, Inc., and Nicholas Mitrokostas of Goodwin Procter, LLP will help patent owners and their counsel navigate both patent prosecution and litigation issues related to patent term by drawing on insights from three recent Federal Circuit decisions: Novartis AG v. [read post]
26 Sep 2022, 3:10 pm
Hargis Indus., 575 U.S. 138 (2015); Medtronic, Inc. v. [read post]
13 Mar 2022, 8:58 pm
Stephen Bauer (retired, Medtronic Inc.), Dean Harts of 3M Innovative Properties Co., Sharon Reiche of Pfizer Inc., and Bill Warren of Eversheds Sutherland will provide an overview of significant IP policy concerns across different countries and regions based on IPO's comments made during the U.S. [read post]
26 Sep 2022, 3:10 pm
Hargis Indus., 575 U.S. 138 (2015); Medtronic, Inc. v. [read post]
6 Jul 2011, 4:30 am
Medtronic, Inc. and Saracare Corp., 5:11-CV-144/RS-CJK, 2011 WL 2473318 (N.D. [read post]
7 Sep 2010, 12:10 pm
Following one of our fave decisions, In re Medtronic, Inc., 592 F. [read post]
17 Sep 2013, 11:31 am
Medtronic, Inc., 921 F. [read post]
8 Aug 2007, 11:40 am
Medtronic Vascular, Inc., 486 F. [read post]
28 Sep 2011, 1:04 pm
We don't see many successful applications of preemption with respect to 510k, Class II medical devices since Medtronic, Inc. v. [read post]
10 Aug 2011, 1:04 pm
Medtronics [sic], Inc., C.A. [read post]
11 Feb 2007, 6:51 am
Atrix Laboratories, Inc. and Sanofi-Synthelabo Inc. [read post]
